Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928624 · ClinicalTrials.gov registry record · NA
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT05928624 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 69 participants.
The verdict
NCT05928624, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.
Interventions
- OTHER Standard of Care
- DEVICE Withings Home Blood Pressure Device and Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05928624
The ClinicalTrials.gov registry entry for NCT05928624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05928624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05928624 about?
NCT05928624 is a clinical study titled "A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients". This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.
What is the current status of trial NCT05928624?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2023-09-22. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT05928624?
The interventions under investigation include: Standard of Care (OTHER), Withings Home Blood Pressure Device and Scale (DEVICE).
Who is sponsoring clinical trial NCT05928624?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.